CN111330065A - 医用复合纤维、制备方法以及组织修复敷料 - Google Patents
医用复合纤维、制备方法以及组织修复敷料 Download PDFInfo
- Publication number
- CN111330065A CN111330065A CN202010209641.3A CN202010209641A CN111330065A CN 111330065 A CN111330065 A CN 111330065A CN 202010209641 A CN202010209641 A CN 202010209641A CN 111330065 A CN111330065 A CN 111330065A
- Authority
- CN
- China
- Prior art keywords
- fiber
- medical composite
- composite fiber
- chitosan
- tissue repair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 148
- 239000002131 composite material Substances 0.000 title claims abstract description 80
- 230000017423 tissue regeneration Effects 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 229920001661 Chitosan Polymers 0.000 claims abstract description 83
- 210000001691 amnion Anatomy 0.000 claims abstract description 44
- 239000000126 substance Substances 0.000 claims abstract description 37
- -1 amino polysaccharide Chemical class 0.000 claims abstract description 23
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 23
- 239000005017 polysaccharide Substances 0.000 claims abstract description 23
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 29
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 29
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 29
- 230000005588 protonation Effects 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 24
- 238000002791 soaking Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 241000282414 Homo sapiens Species 0.000 claims description 7
- 241001494479 Pecora Species 0.000 claims description 7
- 241000283690 Bos taurus Species 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 6
- 241000282898 Sus scrofa Species 0.000 claims description 6
- 238000005917 acylation reaction Methods 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 abstract description 13
- 230000009286 beneficial effect Effects 0.000 abstract description 12
- 210000001519 tissue Anatomy 0.000 abstract description 8
- 230000021164 cell adhesion Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 238000005213 imbibition Methods 0.000 abstract description 2
- 239000004744 fabric Substances 0.000 description 28
- 230000000052 comparative effect Effects 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 17
- 238000004113 cell culture Methods 0.000 description 16
- 239000000047 product Substances 0.000 description 11
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 238000011068 loading method Methods 0.000 description 10
- 238000000116 DAPI staining Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 230000003385 bacteriostatic effect Effects 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 108010067770 Endopeptidase K Proteins 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000001878 scanning electron micrograph Methods 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 230000037314 wound repair Effects 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000010609 cell counting kit-8 assay Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 108010087230 Sincalide Proteins 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000010393 epithelial cell migration Effects 0.000 description 2
- 230000009786 epithelial differentiation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000008556 epithelial cell proliferation Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
- A61F13/01012—Non-adhesive bandages or dressings characterised by the material being made of natural material, e.g. cellulose-, protein-, collagen-based
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
实施例编号 | 1 | 2 | 3 | 4 | 5 |
D1/微米 | 15 | 2000 | 0.05 | 500 | 0.5 |
M1/万 | 100 | 500 | 5 | 200 | 20 |
实施例编号 | 1 | 2 | 3 | 4 | 5 |
T1/摄氏度 | 25 | 30 | 20 | 5 | 0 |
t1/分钟 | 120 | 1 | 30 | 300 | 600 |
T2/摄氏度 | 25 | 30 | 0 | -10 | 5 |
t2/分钟 | 1 | 300 | 720 | 60 | 30 |
实施例编号 | 1 | 2 | 3 | 4 | 5 |
D3/微米 | 15 | 2000 | 0.05 | 500 | 0.5 |
W4/% | 15 | 0.1 | 3 | 33 | 50 |
W5/% | 18 | 30 | 1 | 55 | 95 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010209641.3A CN111330065A (zh) | 2020-03-23 | 2020-03-23 | 医用复合纤维、制备方法以及组织修复敷料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010209641.3A CN111330065A (zh) | 2020-03-23 | 2020-03-23 | 医用复合纤维、制备方法以及组织修复敷料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111330065A true CN111330065A (zh) | 2020-06-26 |
Family
ID=71174718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010209641.3A Pending CN111330065A (zh) | 2020-03-23 | 2020-03-23 | 医用复合纤维、制备方法以及组织修复敷料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111330065A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114344549A (zh) * | 2021-12-13 | 2022-04-15 | 动之医学技术(上海)有限公司 | 复合羊膜敷料及其制备方法 |
WO2022201113A1 (en) * | 2021-03-26 | 2022-09-29 | Advamedica Inc. | Superabsorbent chitosan wound dressings, manufacturing methods and applications thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060134158A1 (en) * | 2002-06-28 | 2006-06-22 | Chemical Biology Institute | Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells |
US20140348940A1 (en) * | 2012-09-10 | 2014-11-27 | Wake Forest University Health Sciences | Amniotic Membrane Hydrogel and Methods of Making |
CN106880867A (zh) * | 2017-02-08 | 2017-06-23 | 吴欣 | 一种止血防粘连膜及其制备方法 |
US20170203004A1 (en) * | 2014-10-02 | 2017-07-20 | Wake Forest University Health Sciences | Amniotic membrane powder and its use in wound healing and tissue engineering constructs |
CN107441547A (zh) * | 2016-05-30 | 2017-12-08 | 四川大学华西医院 | 一种创伤修复材料及其制备方法和用途 |
CN109288867A (zh) * | 2018-10-26 | 2019-02-01 | 上海慧存医疗科技有限公司 | 一种复合羊膜粉制剂的制备方法 |
-
2020
- 2020-03-23 CN CN202010209641.3A patent/CN111330065A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060134158A1 (en) * | 2002-06-28 | 2006-06-22 | Chemical Biology Institute | Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells |
US20140348940A1 (en) * | 2012-09-10 | 2014-11-27 | Wake Forest University Health Sciences | Amniotic Membrane Hydrogel and Methods of Making |
US20170203004A1 (en) * | 2014-10-02 | 2017-07-20 | Wake Forest University Health Sciences | Amniotic membrane powder and its use in wound healing and tissue engineering constructs |
CN107441547A (zh) * | 2016-05-30 | 2017-12-08 | 四川大学华西医院 | 一种创伤修复材料及其制备方法和用途 |
CN106880867A (zh) * | 2017-02-08 | 2017-06-23 | 吴欣 | 一种止血防粘连膜及其制备方法 |
CN109288867A (zh) * | 2018-10-26 | 2019-02-01 | 上海慧存医疗科技有限公司 | 一种复合羊膜粉制剂的制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022201113A1 (en) * | 2021-03-26 | 2022-09-29 | Advamedica Inc. | Superabsorbent chitosan wound dressings, manufacturing methods and applications thereof |
CN114344549A (zh) * | 2021-12-13 | 2022-04-15 | 动之医学技术(上海)有限公司 | 复合羊膜敷料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bahadoran et al. | Development of a polyvinyl alcohol/sodium alginate hydrogel-based scaffold incorporating bFGF-encapsulated microspheres for accelerated wound healing | |
Wang et al. | Collagen/chitosan based two-compartment and bi-functional dermal scaffolds for skin regeneration | |
Zhang et al. | Preparation of collagen–chondroitin sulfate–hyaluronic acid hybrid hydrogel scaffolds and cell compatibility in vitro | |
CN111662464A (zh) | 一种壳聚糖/海藻酸钠双网络水凝胶的制备方法 | |
Chiu et al. | Development of two alginate-based wound dressings | |
CN110772379B (zh) | 一种负载纳米酶的复合纳米纤维膜的制备方法及其创面敷贴 | |
CN111330065A (zh) | 医用复合纤维、制备方法以及组织修复敷料 | |
WO2009042829A1 (en) | Bioactive hydrogel fibers | |
JP2019006802A (ja) | ポリマー−キレーター複合体 | |
Rujitanaroj et al. | Polysaccharide electrospun fibers with sulfated poly (fucose) promote endothelial cell migration and VEGF-mediated angiogenesis | |
US5858392A (en) | Supported polyionic hydrogels | |
CN110747534A (zh) | 一种抗菌多糖纤维材料及其制备方法 | |
Lai | Influence of solvent composition on the performance of carbodiimide cross-linked gelatin carriers for retinal sheet delivery | |
Akia et al. | Antibacterial activity of polymeric nanofiber membranes impregnated with Texas sour orange juice | |
Kim et al. | Effect of RGDS and KRSR peptides immobilized on silk fibroin nanofibrous mats for cell adhesion and proliferation | |
CN114606189A (zh) | 一种促进神经干细胞增殖分化的脱细胞脊髓- GelMA水凝胶复合材料支架 | |
Wang et al. | Construction of cytokine reservoirs based on sulfated chitosan hydrogels for the capturing of VEGF in situ | |
Khandan-Nasab et al. | Design and characterization of adipose-derived mesenchymal stem cell loaded alginate/pullulan/hyaluronic acid hydrogel scaffold for wound healing applications | |
CN115975224A (zh) | 一种pH/ROS双响应的组织粘附载药水凝胶及其制备方法和应用 | |
CN108676769B (zh) | 一种促进肝细胞生长的无纺布支架材料及其制备方法 | |
Li et al. | Cellulose nanofibers embedded chitosan/tannin hydrogel with high antibacterial activity and hemostatic ability for drug-resistant bacterial infected wound healing | |
Liu et al. | Multifunctional antibiotics-free hydrogel dressings with self-regulated nitric oxide-releasing kinetics for improving open wound healing | |
Chen et al. | Polydopamine modified acellular dermal matrix sponge scaffold loaded with a-FGF: Promoting wound healing of autologous skin grafts | |
WO2005019518A1 (en) | Functionalization of yarn and textile products | |
Kirwale et al. | Chitosan, chondroitin sulfate, and hyaluronic acid based in-situ forming scaffold for efficient cell grafting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhu Xuejing Inventor before: Zhu Xuejing Inventor before: Yan Hexin |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No. 81-82, Lane 887, Zuchongzhi Road, Pudong New Area, Shanghai, October 2012, 2F North Applicant after: Dynamic medical technology (Shanghai) Co.,Ltd. Applicant after: SHANGHAI CRYOWISE MEDICAL TECHNOLOGY Co.,Ltd. Address before: Room 102, Building 9, No. 1206 Zhangjiang Road, Pudong New Area, Shanghai, March 2012 Applicant before: Dynamic medical technology (Shanghai) Co.,Ltd. Applicant before: SHANGHAI CRYOWISE MEDICAL TECHNOLOGY Co.,Ltd. |